As treatment for schizophrenia changes, LAIs are becoming increasingly important as maintenance therapy. Teva's pursuit of an ...

Kristin Alvarez, PharmD, BCPS, is the director of clinical innovation at Parkland Health & Hospital System in Dallas, Texas. In her current role, she leads the Center for Innovation and Value at ...

Adherence concerns remain one of the most recalcitrant problems in healthcare today. Estimates indicate that the cost of poor adherence is nearing $300 billion per year. While there are many ...

The impact of non-adherence to medication is well documented and largely undisputed. Multiple studies have shown that patients’ failure to remain committed to their prescribed course of therapy ...

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up The seamless integration delivers crucial insights into a patient ...

Lenacapavir shows high efficacy in HIV prevention, achieving a 96% reduction in infections compared to F/TDF. The PURPOSE 2 trial demonstrates lenacapavir's superior adherence, with 91% of ...

Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH) Among 4,353 patients, we ...

The new CMS Interoperability Framework aims to harmonize protections across covered entities, business associates and patient ...

Using Infrastructure-as-Code to manage containers has set an industry pattern for Security as Code (SaC) and Policy as Code ...